Literature DB >> 14722813

The role of bone marrow stem cells in liver regeneration.

Markus Grompe1.   

Abstract

Hepatic oval cells involved in some forms of liver regeneration express many markers also found on hematopoietic stem cells (HSCs). In addition, multiple independent reports have demonstrated that bone marrow cells can give rise to several hepatic epithelial cell types, including oval cells, hepatocytes, and duct epithelium. These observations have resulted in the hypothesis that bone marrow resident stem cells, specifically HSCs, are an important source for liver epithelial cell replacement, particularly during chronic injury. The function of such stem cells in hepatic injury responses is the topic of this article. Taken together, the published data on the role of bone marrow stem cells in liver damage suggest that they do not play a significant physiological role in the replacement of epithelial cells in any known form of hepatic injury. Fully functional bone marrow-derived hepatocytes exist but are extremely rare and are generated by cell fusion, not stem cell differentiation. Nonetheless, bone marrow-derived cells may play important indirect roles in liver regeneration. First, they may serve as a source for the replacement of endothelial cells. Second, hematopoietic cells, including lymphocytes, neutrophils, macrophages, and platelets, may provide crucial factors required for efficient healing of damaged liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14722813     DOI: 10.1055/s-2004-815560

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  21 in total

Review 1.  Plasticity and maintenance of hematopoietic stem cells during development.

Authors:  Suman Kanji; Vincent J Pompili; Hiranmoy Das
Journal:  Recent Pat Biotechnol       Date:  2011-04

Review 2.  Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential.

Authors:  Karl J L Fernandes; Jean G Toma; Freda D Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

3.  Stem cells: From embryology to cellular therapy? An appraisal of the present state of art.

Authors:  Sandro Eridani; Vittorio Sgaramella; Lidia Cova
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

4.  Correction of copper metabolism is not sustained long term in Wilson's disease mice post bone marrow transplantation.

Authors:  Nicole E Buck; Daphne M Y Cheah; Ngaire J Elwood; Paul F A Wright; Katrina J Allen
Journal:  Hepatol Int       Date:  2007-12-28       Impact factor: 6.047

Review 5.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

6.  Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver.

Authors:  Jun Xu; Yong Hu; Jian Wang; Ji Zhou; Taiping Zhang; Hongyu Yu
Journal:  Front Med China       Date:  2007-07

Review 7.  Adult stem cells and cancer stem cells: tie in or tear apart?

Authors:  Bin-Bin Liu; Lun-Xiu Qin; Yin-Kun Liu
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

8.  Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.

Authors:  P Szumilas; K Barcew; M Baśkiewicz-Masiuk; B Wiszniewska; M Z Ratajczak; B Machaliński
Journal:  Cell Prolif       Date:  2005-02       Impact factor: 6.831

Review 9.  Current themes in molecular pediatrics: molecular medicine and its applications.

Authors:  Andrea Superti-Furga; Livia Garavelli
Journal:  Ital J Pediatr       Date:  2010-02-19       Impact factor: 2.638

10.  Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration.

Authors:  E Scott Swenson; Reiichiro Kuwahara; Diane S Krause; Neil D Theise
Journal:  Liver Int       Date:  2008-03       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.